Intranasal delivery of growth differentiation factor 5 to the central nervous system

Microemulsion based intranasal delivery system for treatment of insomnia

(2009) Sheetal Porecha et al.   DRUG DELIVERY

Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations

(2009) Mattia M. Migliore et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations

(2009) Shyeilla V. Dhuria et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

(2009) L. R. Hanson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system

(2008) Shyeilla V. Dhuria et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins

(2008) N. Nonaka et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Intracavernous Growth Differentiation Factor‐5 Therapy Enhances the Recovery of Erectile Function in a Rat Model of Cavernous Nerve Injury

(2008) Thomas M. Fandel et al.   Journal of Sexual Medicine

Delivery of interferon-β to the monkey nervous system following intranasal administration

(2008) R.G. Thorne et al.   NEUROSCIENCE

Direct transport of VEGF from the nasal cavity to brain

(2008) Ji-Ping Yang et al.   NEUROSCIENCE LETTERS

Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

(2008) Stuart T. Charlton et al.   PHARMACEUTICAL RESEARCH